FDA Should Consider Ethicist For Drug Safety Oversight Board, Science Board Chair Says
This article was originally published in The Pink Sheet Daily
Executive Summary
An ethicist could provide input on risk/benefit issues on behalf of the public, UT’s Shine suggests.
You may also be interested in...
Drug Safety Bulletin Being Considered By FDA
The effort would be overseen by new Associate Center Director for Safety Policy & Communication Paul Seligman.
Drug Safety Bulletin Being Considered By FDA
The effort would be overseen by new Associate Center Director for Safety Policy & Communication Paul Seligman.
Drug Safety Oversight Efforts Paying Off, CDER’s Galson Says
The agency has held 29 advisory committee meetings on drug safety since February 2005, according to the CDER director.